{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T21:22:40Z","timestamp":1794950560932,"version":"4.9.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s10549-023-07074-z","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T04:02:30Z","timestamp":1692849750000},"page":"297-304","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Frequency of germline pathogenic variants in breast cancer predisposition genes among young Turkish breast cancer patients"],"prefix":"10.1007","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2690-3067","authenticated-orcid":false,"given":"Aysun Dauti","family":"Isiklar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9436-9279","authenticated-orcid":false,"given":"Lamiya","family":"Aliyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1289-7866","authenticated-orcid":false,"given":"Ahmet","family":"Yesilyurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4206-8738","authenticated-orcid":false,"given":"Aykut","family":"Soyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0775-6180","authenticated-orcid":false,"given":"Gul","family":"Basaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"7074_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M, Morgan E, Rumgay H et al (2022) Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast 66:15\u201323. https:\/\/doi.org\/10.1016\/j.breast.2022.08.010","journal-title":"Breast"},{"key":"7074_CR2","doi-asserted-by":"publisher","unstructured":"Paluch-Shimon S, Cardoso F, Partridge AH et al (2022) ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5). Ann Oncol 33(11):1097\u20131118. https:\/\/doi.org\/10.1016\/j.annonc.2022.07.007","DOI":"10.1016\/j.annonc.2022.07.007"},{"issue":"2","key":"7074_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10549-020-06003-8","volume":"186","author":"V Sopik","year":"2021","unstructured":"Sopik V (2021) International variation in breast cancer incidence and mortality in young women. Breast Cancer Res Treat 186(2):497\u2013507. https:\/\/doi.org\/10.1007\/s10549-020-06003-8","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"7074_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3322\/caac.21555","volume":"69","author":"CE DeSantis","year":"2019","unstructured":"DeSantis CE, Miller KD, Goding Sauer A, Jemal A, Siegel RL (2019) Cancer statistics for African Americans, 2019. CA Cancer J Clin 69(3):211\u2013233. https:\/\/doi.org\/10.3322\/caac.21555","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"7074_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.5152\/ejbh.2019.4890","volume":"15","author":"V Ozmen","year":"2019","unstructured":"Ozmen V, Ozmen T, Dogru V (2019) Breast cancer in Turkey: an analysis of 20,000 patients with breast cancer. Eur J Breast Health 15(3):141\u2013146. https:\/\/doi.org\/10.5152\/ejbh.2019.4890","journal-title":"Eur J Breast Health"},{"issue":"6","key":"7074_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1159\/000503219","volume":"14","author":"U Dafni","year":"2019","unstructured":"Dafni U, Tsourti Z, Alatsathianos I (2019) Breast cancer statistics in the European Union: incidence and survival across European Countries. Breast Care (Basel) 14(6):344\u2013353. https:\/\/doi.org\/10.1159\/000503219","journal-title":"Breast Care (Basel)"},{"key":"7074_CR7","unstructured":"Petrucelli N, Daly MB, Pal T (1998) BRCA1- and BRCA2-associated hereditary breast and ovarian cancer. 1998 Sept 4 (Updated 2022 May 26). In: Adam MP, Mirzaa GM, Pagon RA et al (eds) GeneReviews\u00ae (Internet). University of Washington, Seattle, WA, 1993\u20132023. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1247\/"},{"key":"7074_CR8","doi-asserted-by":"publisher","unstructured":"Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies [published correction appears in Am J Hum Genet. 2003 Sept;73(3):709]. Am J Hum Genet 72(5):1117\u20131130. https:\/\/doi.org\/10.1086\/375033","DOI":"10.1086\/375033"},{"key":"7074_CR9","unstructured":"NCCN Guidelines for Genetics\/Familial High-Risk Assessment: Breast and Ovarian V.1.2019\u2014web teleconference on 04\/10\/18"},{"issue":"5","key":"7074_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"7074_CR11","doi-asserted-by":"publisher","first-page":"9645147","DOI":"10.1155\/2019\/9645147","volume":"2019","author":"C Geredeli","year":"2019","unstructured":"Geredeli C, Yasar N, Sakin A (2019) Germline mutations in BRCA1 and BRCA2 in breast cancer patients with high genetic risk in Turkish population. Int J Breast Cancer 2019:9645147. https:\/\/doi.org\/10.1155\/2019\/9645147","journal-title":"Int J Breast Cancer"},{"issue":"6","key":"7074_CR12","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1054\/bjoc.2000.1332","volume":"83","author":"H Yazici","year":"2000","unstructured":"Yazici H, Bitisik O, Akisik E, Cabioglu N, Saip P et al (2000) BRCA1 and BRCA2 mutations in Turkish breast\/ovarian families and young breast cancer patients. Br J Cancer 83(6):737\u2013742. https:\/\/doi.org\/10.1054\/bjoc.2000.1332","journal-title":"Br J Cancer"},{"key":"7074_CR13","doi-asserted-by":"publisher","unstructured":"Bilgic DG, Gumus AA, Bilgic A, Cam FS (2022) Mutations of BRCA 1\/2 genes in the west of Turkey and genotype-phenotype correlations. Clin Lab. https:\/\/doi.org\/10.7754\/Clin.Lab.2021.210425","DOI":"10.7754\/Clin.Lab.2021.210425"},{"issue":"2","key":"7074_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5152\/ejbh.2017.3799","volume":"14","author":"H Yazici","year":"2018","unstructured":"Yazici H, Kilic S, Akdeniz D et al (2018) Frequency of rearrangements versus small indels mutations in BRCA1 and BRCA2 genes in Turkish patients with high risk breast and ovarian cancer. Eur J Breast Health 14(2):93\u201399. https:\/\/doi.org\/10.5152\/ejbh.2017.3799","journal-title":"Eur J Breast Health"},{"key":"7074_CR15","doi-asserted-by":"publisher","unstructured":"Akin Duman T, Ozturk FN (2023) Frequency and distribution of BRCA1\/BRCA2 large genomic rearrangements in Turkish population with breast cancer (published online ahead of print, 2023 Mar 3). J Hum Genet. https:\/\/doi.org\/10.1038\/s10038-023-01140-6","DOI":"10.1038\/s10038-023-01140-6"},{"key":"7074_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.06.005","volume":"65","author":"A Bisgin","year":"2022","unstructured":"Bisgin A, Ozemri SS, Dogan ME, Yildiri\u00f6 MS et al (2022) Germline landscape of BRCAs by 7-site collaborations as a BRCA consortium in Turkey. Breast 65:15\u201322. https:\/\/doi.org\/10.1016\/j.breast.2022.06.005","journal-title":"Breast"},{"issue":"1","key":"7074_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10549-015-3377-4","volume":"151","author":"E Kang","year":"2015","unstructured":"Kang E, Seong MW, Park SK et al (2015) The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study. Breast Cancer Res Treat 151(1):157\u2013168. https:\/\/doi.org\/10.1007\/s10549-015-3377-4","journal-title":"Breast Cancer Res Treat"},{"key":"7074_CR18","doi-asserted-by":"publisher","unstructured":"ElBiad O, Laraqui A, El Boukhrissi F et al (2022) Prevalence of specific and recurrent\/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-022-09181-4","DOI":"10.1186\/s12885-022-09181-4"},{"issue":"1","key":"7074_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41523-021-00317-6","volume":"7","author":"JS Herzog","year":"2021","unstructured":"Herzog JS, Chavarri-Guerra Y, Castillo D et al (2021) Genetic epidemiology of BRCA1- and BRCA2-associated cancer across Latin America. NPJ Breast Cancer 7(1):107. https:\/\/doi.org\/10.1038\/s41523-021-00317-6","journal-title":"NPJ Breast Cancer"},{"issue":"4","key":"7074_CR20","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/ijc.11271","volume":"106","author":"S de Sanjos\u00e9","year":"2003","unstructured":"de Sanjos\u00e9 S, L\u00e9on\u00e9 M, B\u00e9rez V et al (2003) Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study. Int J Cancer 106(4):588\u2013593. https:\/\/doi.org\/10.1002\/ijc.11271","journal-title":"Int J Cancer"},{"issue":"1","key":"7074_CR21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1186\/s12885-020-07352-9","volume":"20","author":"J Bakkach","year":"2020","unstructured":"Bakkach J, Mansouri M, Derkaoui T et al (2020) Contribution of BRCA1 and BRCA2 germline mutations to early onset breast cancer: a series from north of Morocco. BMC Cancer 20(1):859. https:\/\/doi.org\/10.1186\/s12885-020-07352-9","journal-title":"BMC Cancer"},{"issue":"24","key":"7074_CR22","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1001\/jama.298.24.2869","volume":"298","author":"EM John","year":"2007","unstructured":"John EM, Miron A, Gong G et al (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial\/ethnic groups. JAMA 298(24):2869\u20132876. https:\/\/doi.org\/10.1001\/jama.298.24.2869","journal-title":"JAMA"},{"key":"7074_CR23","doi-asserted-by":"publisher","first-page":"938561","DOI":"10.3389\/fonc.2022.938561","volume":"12","author":"NC van der Merwe","year":"2022","unstructured":"van der Merwe NC, Ntaita KS, Stofberg H et al (2022) Implementation of multigene panel testing for breast and ovarian cancer in South Africa: a step towards excellence in oncology for the public sector. Front Oncol 12:938561. https:\/\/doi.org\/10.3389\/fonc.2022.938561","journal-title":"Front Oncol"},{"issue":"2","key":"7074_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10549-006-9303-z","volume":"102","author":"KD Awadelkarim","year":"2007","unstructured":"Awadelkarim KD, Aceto G, Veschi S et al (2007) BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors. Breast Cancer Res Treat 102(2):189\u2013199. https:\/\/doi.org\/10.1007\/s10549-006-9303-z","journal-title":"Breast Cancer Res Treat"},{"key":"7074_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12885-016-2107-6","volume":"16","author":"WM Cao","year":"2016","unstructured":"Cao WM, Gao Y, Yang HJ et al (2016) Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast\/ovarian cancer. BMC Cancer 16:64. https:\/\/doi.org\/10.1186\/s12885-016-2107-6","journal-title":"BMC Cancer"},{"issue":"2","key":"7074_CR26","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/ijc.33199","volume":"148","author":"IM Akcay","year":"2021","unstructured":"Akcay IM, Celik E, Agaoglu NB et al (2021) Germline pathogenic variant spectrum in 25 cancer susceptibility genes in Turkish breast and colorectal cancer patients and elderly controls. Int J Cancer 148(2):285\u2013295. https:\/\/doi.org\/10.1002\/ijc.33199","journal-title":"Int J Cancer"},{"key":"7074_CR27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.cancergen.2022.02.006","volume":"262\u2013263","author":"E Bora","year":"2022","unstructured":"Bora E, Caglayan AO, Koc A et al (2022) Evaluation of hereditary\/familial breast cancer patients with multigene targeted next generation sequencing panel and MLPA analysis in Turkey. Cancer Genet 262\u2013263:118\u2013133. https:\/\/doi.org\/10.1016\/j.cancergen.2022.02.006","journal-title":"Cancer Genet"},{"issue":"2","key":"7074_CR28","doi-asserted-by":"publisher","first-page":"150","DOI":"10.4274\/MMJ.galenos.2022.22556","volume":"37","author":"E Arslan Ates","year":"2022","unstructured":"Arslan Ates E, Turkyilmaz A, Alavanda C et al (2022) Multigene panel testing in Turkish hereditary cancer syndrome patients. Medeni Med J 37(2):150\u2013158. https:\/\/doi.org\/10.4274\/MMJ.galenos.2022.22556","journal-title":"Medeni Med J"},{"issue":"6","key":"7074_CR29","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.1016\/j.clbc.2021.04.002","volume":"21","author":"A Ece Solmaz","year":"2021","unstructured":"Ece Solmaz A, Yeniay L, G\u00f6kmen E et al (2021) Clinical contribution of next-generation sequencing multigene panel testing for BRCA negative high-risk patients with breast cancer. Clin Breast Cancer 21(6):e647\u2013e653. https:\/\/doi.org\/10.1016\/j.clbc.2021.04.002","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"7074_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ygyno.2010.05.018","volume":"119","author":"D Aktas","year":"2010","unstructured":"Aktas D, Gultekin M, Kabacam S et al (2010) Identification of point mutations and large rearrangements in the BRCA1 gene in 667 Turkish unselected ovarian cancer patients. Gynecol Oncol 119(1):131\u2013135. https:\/\/doi.org\/10.1016\/j.ygyno.2010.05.018","journal-title":"Gynecol Oncol"},{"issue":"8","key":"7074_CR31","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/gim.2014.176","volume":"17","author":"KN Maxwell","year":"2015","unstructured":"Maxwell KN, Wubbenhorst B, D\u2019Andrea K et al (2015) Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA 1\/2-negative patients with early-onset breast cancer. Genet Med 17(8):630\u2013638. https:\/\/doi.org\/10.1038\/gim.2014.176","journal-title":"Genet Med"},{"issue":"1","key":"7074_CR32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/genes14010106","volume":"14","author":"A Nassar","year":"2022","unstructured":"Nassar A, Zekri AN, Kamel MM et al (2022) Frequency of pathogenic germline mutations in early and late onset familial breast cancer patients using multi-gene panel sequencing: an Egyptian study. Genes (Basel) 14(1):106. https:\/\/doi.org\/10.3390\/genes14010106","journal-title":"Genes (Basel)"},{"issue":"3","key":"7074_CR33","doi-asserted-by":"publisher","first-page":"697","DOI":"10.4143\/crt.2019.559","volume":"52","author":"HC Shin","year":"2020","unstructured":"Shin HC, Lee HB, Yoo TK et al (2020) Detection of germline mutations in breast cancer patients with clinical features of hereditary cancer syndrome using a multi-gene panel test. Cancer Res Treat 52(3):697\u2013713. https:\/\/doi.org\/10.4143\/crt.2019.559","journal-title":"Cancer Res Treat"},{"issue":"11","key":"7074_CR34","doi-asserted-by":"publisher","first-page":"e500","DOI":"10.1002\/mgg3.1500","volume":"8","author":"JP Uyisenga","year":"2020","unstructured":"Uyisenga JP, Segers K, Lumaka AZ et al (2020) Screening of germline mutations in young Rwandan patients with breast cancers. Mol Genet Genomic Med 8(11):e500. https:\/\/doi.org\/10.1002\/mgg3.1500","journal-title":"Mol Genet Genomic Med"},{"issue":"2","key":"7074_CR35","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/ijc.31601","volume":"144","author":"JY Li","year":"2019","unstructured":"Li JY, Jing R, Wei H et al (2019) Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancer. Int J Cancer 144(2):281\u2013289. https:\/\/doi.org\/10.1002\/ijc.31601","journal-title":"Int J Cancer"},{"issue":"1","key":"7074_CR36","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1038\/s41467-018-06581-8","volume":"9","author":"Y Momozawa","year":"2018","unstructured":"Momozawa Y, Iwasaki Y, Parsons MT et al (2018) Germline pathogenic variants of 11 breast cancer genes in 7051 Japanese patients and 11,241 controls. Nat Commun 9(1):4083. https:\/\/doi.org\/10.1038\/s41467-018-06581-8","journal-title":"Nat Commun"},{"key":"7074_CR37","doi-asserted-by":"publisher","unstructured":"Tung NM, Robson ME, Ventz S et al (2020) TBCRC 048: phase II study of olaparib for metastatic breast cancer and mutations in homologous recombination-related genes. J Clin Oncol 38(36):4274\u20134282. https:\/\/doi.org\/10.1200\/JCO.20.02151","DOI":"10.1200\/JCO.20.02151"},{"key":"7074_CR38","doi-asserted-by":"publisher","unstructured":"Geyer CE Jr, Garber JE, Gelber RD et al (2022) Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA 1\/2 and high-risk, early breast cancer. Ann Oncol 33(12):1250\u20131268. https:\/\/doi.org\/10.1016\/j.annonc.2022.09.159","DOI":"10.1016\/j.annonc.2022.09.159"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07074-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-023-07074-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07074-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T19:05:58Z","timestamp":1694977558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-023-07074-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["7074"],"URL":"https:\/\/doi.org\/10.1007\/s10549-023-07074-z","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,24]]},"assertion":[{"value":"3 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval of this retrospective study was granted in 2020 by (our university) Ethics Committee (Approval # 01.09.2020\/754).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants signed a written informed consent form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}